Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6.99M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2.03M
-
Shares change
-
-250K
-
Total reported value, excl. options
-
$18.7M
-
Value change
-
-$2M
-
Number of buys
-
10
-
Number of sells
-
-10
-
Price
-
$9.24
Significant Holders of Minerva Neurosciences, Inc. - Common Stock (NERV) as of Q3 2022
28 filings reported holding NERV - Minerva Neurosciences, Inc. - Common Stock as of Q3 2022.
Minerva Neurosciences, Inc. - Common Stock (NERV) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.03M shares
of 6.99M outstanding shares and own 29.01% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1.2M shares), Artal Group S.A. (250K shares), VANGUARD GROUP INC (164K shares), RENAISSANCE TECHNOLOGIES LLC (102K shares), BlackRock Inc. (78.1K shares), GEODE CAPITAL MANAGEMENT, LLC (39.8K shares), ACADIAN ASSET MANAGEMENT LLC (29.7K shares), MILLENNIUM MANAGEMENT LLC (28.6K shares), FMR LLC (28.3K shares), and Point72 Asset Management, L.P. (25K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.